PMab-38 Recognizes Canine Podoplanin of Squamous Cell Carcinomas

Mika K. Kaneko, Ryusuke Honma, Satoshi Ogasawara, Yuki Fujii, Takuro Nakamura, Noriko Saidoh, Michiaki Takagi, Yumiko Kagawa, Satoru Konnai, Yukinari Kato

研究成果: Article査読

13 被引用数 (Scopus)

抄録

Podoplanin, a type I transmembrane protein, is expressed in lymphatic endothelial cells. Although we previously developed an anticanine podoplanin monoclonal antibody (mAb), PMab-38, immunohistochemistry (IHC) showed that it did not react with canine lymphatic endothelial cells. Here, we determined whether PMab-38 recognizes canine podoplanin of squamous cell carcinomas (SCCs) and clarified its epitope. In IHC, PMab-38 reacted with 83% of SCCs (15/18 cases). Flow cytometry showed that the epitope of PMab-38 was different from that of the platelet aggregation-stimulating domain of the N-terminus, which was detected by almost all antipodoplanin mAbs such as D2-40 or NZ-1. PMab-38 is expected to be useful for investigating the function of podoplanin in canine tumors.

本文言語English
ページ(範囲)263-266
ページ数4
ジャーナルMonoclonal antibodies in immunodiagnosis and immunotherapy
35
5
DOI
出版ステータスPublished - 2016 10

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

フィンガープリント 「PMab-38 Recognizes Canine Podoplanin of Squamous Cell Carcinomas」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル